RU94037731A - Method for treating multiple sclerosis
- Google Patents
Method for treating multiple sclerosis
Info
Publication number
RU94037731A
RU94037731ARU94037731/14ARU94037731ARU94037731ARU 94037731 ARU94037731 ARU 94037731ARU 94037731/14 ARU94037731/14 ARU 94037731/14ARU 94037731 ARU94037731 ARU 94037731ARU 94037731 ARU94037731 ARU 94037731A
Акционерное общество закрытого типа Научно-производственная компания "Олифен"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное общество закрытого типа Научно-производственная компания "Олифен"filedCriticalАкционерное общество закрытого типа Научно-производственная компания "Олифен"
Priority to RU94037731/14ApriorityCriticalpatent/RU94037731A/en
Publication of RU94037731ApublicationCriticalpatent/RU94037731A/en
FIELD: medicine. SUBSTANCE: method involves applying a drug stimulating immune system on the background of symptomatic and supporting therapy. Olyphen is selected as the drug mentioned. It is given at therapeutic intravenous and/or peroral doses. EFFECT: enhanced effectiveness of treatment.
Claims (1)
Способ лечения рассеянного склероза заключается в том, что в качестве вещества, воздействующего на иммунную систему на фоне симптоматического и поддерживающего лечения, применяют препарат "Олифен" в терапевтических дозах внутривенно и/или перорально.A method of treating multiple sclerosis is that as a substance affecting the immune system against the background of symptomatic and supportive treatment, the drug "Olifen" is used in therapeutic doses intravenously and / or orally.
RU94037731/14A1994-09-301994-09-30Method for treating multiple sclerosis
RU94037731A
(en)
Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment